CompaniesLuc Therapeutics

Luc Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Rebranded/RenamedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

774

By Phase

PHASE3: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
NCT05832931
NCT05836220
Hover over trial bars to see details

Recent Trials

NCT05836220Collaborator
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2
PHASE3Completed
412 participants
Started: May 15, 2023 · Completed: Aug 5, 2025
NCT05832931Collaborator
Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1
PHASE3Completed
362 participants
Started: Apr 28, 2023 · Completed: Jul 28, 2025